[DOI] [PubMed] [Google Scholar] 553.Krawczyk S.A., Haller J.F., Ferrante T., Zoeller R.A., Corkey B.E
Defense lawyers view this stage as an opportunity to potentially narrow the scope of the litigation by dismissing claims associated with counterfeit products or lacking verified medical diagnoses
They are knowledgeable about the potential liability claims that fall outside of workers compensation laws
SGLT2 inhibitors (sodium-glucose cotransporter-2 inhibitors) such as empagliflozin, dapagliflozin, and canagliflozin represent excellent alternatives, providing cardiovascular and renal protection alongside modest weight loss (typically 2-4 kg)
States that make the determination to continue covering these products with tighter restrictions on the eligible population, such as higher BMI thresholds for coverage, must balance the lower volume of eligible patients with the potential loss or reduction of supplemental rebate dollars from the manufacturer(s)
